Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Correction to “Ephedrannin A: A potent dual inhibitor of FAK and Src with anticancer effects”
Correction to “Ephedrannin A: A potent dual inhibitor of FAK and Src with anticancer effects”
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Format:
Artículo Open Access
Published:
Wiley
2026
Subjects:
Bulletin of the Korean Chemical Society
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Description
DOI:
10.1002/bkcs.70175
Similar Items
Ephedrannin A: A potent dual inhibitor of FAK and Src with anticancer effects
by: Hien Thi My Ong, et al.
Published: (2025)
Design, synthesis, and biological evaluation of ring‐expanded thioacetal derivatives as potent and selective butyrylcholinesterase inhibitors
by: Haneul Lee, et al.
Published: (2026)
Discovery of piperazine‐tethered N‐heterocycle derivatives as anticancer agents
by: Young Hee Lee, et al.
Published: (2026)
Vitamins as potent cancer treatments through regulating the activity and expression of MMP ‐2 and MMP ‐9
by: Yen Thi Nguyen, et al.
Published: (2026)
Discovery of 2‐(1,2,4‐triazol‐3‐yl)pyridine KTD‐092 as a novel DYRK1A inhibitor
by: Sujeong Hong, et al.
Published: (2025)
